Price Alert

Drugs Made In America Acq... (DMAA)

NASDAQ: DMAA · Real-Time Price · USD

10.27

0.01 (0.10%)

At close: Aug 21, 2025, 3:59 PM

10.28

0.10%

After-hours: Aug 21, 2025, 04:00 PM EDT

Drugs Made In America Acquisition Ordinary Shares Cash Flow Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024
Net Income	3.69M	1.25M	-279	-144.93K	-54.93
Depreciation & Amortization	n/a	n/a	n/a	n/a	n/a
Stock-Based Compensation	n/a	n/a	n/a	n/a	n/a
Other Working Capital	-67.4K	-70.1K	69.88K	67.4K	-60
Other Non-Cash Items	-3.92M	-1.49M	-69.71K	20.3K	-0.00
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-67.4K	-14.89K	69.88K	67.4K	-60
Operating Cash Flow	-300.67K	-251.24K	-106	-57.23K	-114.93
Capital Expenditures	n/a	4.00	-4	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	-231.15M	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	-231.15M	n/a	n/a	n/a	n/a
Investing Cash Flow	-231.15M	-231.15M	n/a	n/a	n/a
Debt Repayment	n/a	-900K	n/a	317.13K	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	231.47M	250.82K	n/a	87.06K	133.03
Financial Cash Flow	231.47M	231.4M	-638	41.23K	133.03
Net Cash Flow	-1.27K	-428	-744	-16K	18.10
Free Cash Flow	-300.67K	-251.24K	-123	-57.23K	-114.93